Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
About this study
The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies
- Condition
- Malignant Solid Tumors, Primary Brain Tumor, Melanoma, Soft Tissue Sarcoma, Colorectal Cancer, Kidney Cancer, Prostate Cancer
- Sponsor
- N.N. Petrov National Medical Research Center of Oncology
Who can join
- Age
- 1 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 1 years
- Study condition: Malignant Solid Tumors, Primary Brain Tumor, Melanoma, Soft Tissue Sarcoma, Colorectal Cancer, Kidney Cancer, Prostate Cancer
- Signed inform consent
- Histolgically verified solid tumour
- Receiving systemic therapy for neoplasm
- Has archival tumour tissue
- Provide biosamples with living tumour tissue or blood samples for immunologic assessment
Exclusion 6
- Concurrent Lymphoprolipherative disorder
- Patients after stem cell or bone marrow thansplantation
- Incomplete informaton on previous cancer history or medical history
- Patients with known primary immunodeficiency
- Patients receiving immunosupressive therapy for concurrent illness
- Pregnant patients
Where
1 site, 1 recruiting
N.N. Petrov NMRC of Oncology, Oncoimmunology dep.
Saint Petersburg, Russia
Contact
-
Aleksei Novik, MD, PhD
+78124399505 alexey.viktorovich.novik@gmail.com
-
Tatiana Nekhaeva, MD, PhD
+78124399514 nehaevat151274@mail.ru
Potential match only. Final eligibility is determined by the study team.